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Abstract
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has triggered a global health
pandemic that led to substantial morbidity and mortality worldwide. The virus has been known to predominantly cause
severe hypoxemic respiratory failure but there have been multiple reports of extra-pulmonary manifestations. Additionally, there has been increasing evidence of COVID-19 hyper-coagulability. Herein, we present a case of a 49-year-old
male with a past medical history of diet controlled type II diabetes mellitus and recently diagnosed COVID-19 who
presented to the emergency department with a chief complaint of nausea and vomiting. Our patient was found to have a
thrombus-like appearing 1.9 cm £ 1.2 cm well-circumscribed mass, attached to the greater curvature of the ascending
aorta, superior to the right coronary cusp of the aortic valve almost three weeks after his initial diagnosis of COVID-19
virus.
Keywords: Aortic Thrombus, COVID 19, Embolic stroke, Embolisation to coronaries

1. Introduction

I

n COVID-19 patients, coagulation abnormalities
and thrombosis are frequently found despite
prophylactic anticoagulation.1 While most individuals infected with severe acute respiratory
syndrome coronavirus 2 (SARS CoV 2) only experience mild to moderate symptoms, some suffer a
more severe or fatal course of the infection. The
main thrombotic complications are deep vein
thrombosis, microvascular thrombosis, and pulmonary embolism.1 The incidence of venous thromboembolism in COVID-19 patients admitted to the
ICU during COVID-19 infection is reported to be as
high as 27%. Arterial vascular events are seen in up
to 3.7% of cases.2 COVID-19 has been recently
linked to large vessel stroke in young adults.

2. Case presentation
Our patient is a 49-year-old male with a past medical history of diet-controlled type II diabetes Mellitus
who presented to the emergency department with a
chief complaint of nausea and vomiting. He reported
a one-day history of multiple non-bilious, non-bloody
emesis; however, he denied any abdominal pain,
constipation, diarrhea, fever, or chills. Symptoms
were associated with generalized weakness without
any numbness or focal deﬁcits. Furthermore, the patient also endorsed polyuria and polydipsia for two
weeks. He denied any chest pain, palpitations,
shortness of breath, cough, or sore throat.
Moreover, the patient reported testing positive for
SARS-COV-2 three weeks before his presentation to
the emergency department and was experiencing
fatigue and a sore throat.
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Upon presentation to the emergency department,
the patient was awake, alert, and fully orienteto
time, place, and person. He was afebrile and hemodynamically stable but tachycardic with a heart
rate of 110e120 beats per minute and O2 saturation
of 94% on room air.
Lungs were clear to auscultation bilaterally, no
wheezes or crackles were heard. The chest was nontender to palpation. JVP was non-distended, and no
bruits were heard over the neck. On cardiac exam, I
heard normal S1 and S2. No murmur, rubs, gallops,
S3 or S4 were appreciated. The abdomen was soft,
non-distended, and non-tender to palpation with
normoactive bowel sounds. The skin was warm and
dry with no rash. Extremities had no edema, calf
tenderness, or erythema. Left-sided dysmetria with
an abnormal ﬁnger-to-nose test was found on
Neuro examination with normal sensory, motor,
and reﬂex system.
Labs revealed blood glucose of 443 mg/dl
(74e104), with small amounts of acetone, bicarbonate of 18 mmol/l (22e26), and an anion gap of
15 mmol/l (8e10). Troponin was 3.84 ng/ml (<0,05),
brain natriuretic peptide: 761 pg/ml (<100). A white
blood cell count of 16.1 K/UL (4.8e10) and platelet
count of 441K/UL (140e400) was noted. The coagulation proﬁle was aPTT: 22.7 s (23e38 s) and PT 15.1 s
(12.6e12.6). Inﬂammatory markers were CRP
37.1 ng/ml (<1), ESR: 60 mm/h (0e20), D-dimer:
810 ng/ml (0e230). EKG showed an atrial ﬂutter with
the 4:1 atrioventricular conduction, and CT Head
revealed an acute left superior cerebellar stroke.
The patient was admitted to the intensive care
unit (ICU) for management of diabetic ketoacidosis
(DKA) and non-ST segment elevation myocardial
infarction (NSTEMI) associated with a new-onset
superior cerebellar ischemic stroke. Trans-thoracic
echocardiography was performed, which revealed a
left ventricular ejection fraction of 20e25% with severe hypokinesis of the heart's basal, mid inferior,
and lateral walls.
A thrombus-like appearing 1.9 cm  1.2 cm wellcircumscribed mass, attached to the greater curvature of the ascending aorta, superior to the right
coronary cusp of the aortic valve, was also noted
(Image 1). Treatment with therapeutic enoxaparin
and dual-antiplatelet therapy along with goaldirected medical hearty for heart failure was started.
CT angiography and trans-esophageal echocardiography (Image 2) done three days later showed the
absence of the aortic mass but a total occlusion of
the mid-right coronary artery secondary to an
embolus versus thrombus.
The patient did not develop any new neurovascular complications during his hospital stay and

Image 1. Parasternal long axis view on trans-throacic echocardiography
showing a thrombus above the aortic valve.

was discharged on 20 mg rivaroxaban. Cardiac
Catheterization one and a half months later showed
100% occlusion of the mid-right coronary artery
with collaterals from the left anterior descending to
the distal right coronary artery. Also, 50% stenosis of
the obtuse marginal and 40% stenosis of the mid-left
anterior descending artery was noted. The patient
denied any anginal symptoms at this time, and
anticoagulation with rivaroxaban was continued.

3. Discussion
Studies have shown that COVID-19 infection is
frequently complicated by a prothrombotic state and
inﬂammation of the endothelium, which leads to
damage and release of cytokines in the vasculature.
Although venous thromboembolic events have been
well documented in the literature, arterial thromboembolic events are increasingly being reported.
Commonly known presentations are stroke,
myocardial infarctions, aortic thrombosis, limb
ischemia, and mesenteric ischemia.5 Our patient was
found to have an aortic thrombus, which likely

Image 2. Repeat echocardiography three days later shows absence of
thrombus, indicating likely embolization.

embolized to the brain and the right coronary artery.
However, one can argue that the occlusion in the
right coronary artery could be secondary to an acute
on chronic thrombus; in the absence of other signs of
vasculopathy like calciﬁcation of the aorta and young
age of the patient, an embolus seems more likely.
Avila et al. have reported that, in similar COVID-19
infection cases, labs are signiﬁcant for elevated Ddimer and C-reactive protein levels.5 D-dimer above
1000 ng/mL has been associated with increased
mortality.3 Although initially, it was believed that
only medium and small-sized arteries are involved in
thromboembolic events, cases large-sized arterial
involvement is also being increasing reported.4
Albeit thrombus in the ascending aorta is rare due to
high pressure and blood ﬂow in this region, many
such cases are documented. Some known risk factors
for the same in patients with COVID-19 are age >50,
male gender, smoking history, and obesity.
These thrombi can cause severe complications by
embolizing to the viscera and extremities, causing
infarcts.
Gomez-Arbelaez et al. report four cases of arterial
thrombosis in otherwise healthy patients who presented with normal prothrombin time, activated
partial thromboplastin time, and platelet count.6
Although our patient presented with elevated prothrombin time and activated partial thromboplastin
time, the cases described by Gomez-Arbelaez et al.
also had no history of hypercoagulable disease or
atrial ﬁbrillation similar to our patient. Despite the
use of thromboprophylaxis measures, they were
found to have an aortic thrombus.6 Therefore, in
patients presenting with embolic events in the
absence of other risk factors, it is reasonable to
screen for COVID-19. Treatment with therapeutic
anticoagulation with close monitoring for embolic
events is recommended. Prophylactic anticoagulation is vital to prevent these complications;
however, the dose and duration of therapy remain
to be investigated.

4. Conclusion
COVID 19 is a disease with a very high burden on
society regarding physical health and economics. It
is seen to affect both young and old individuals.
Although the disease primarily affects the lungs, it
is considered to be a multi-system disorder
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involving many vital organs. A well-known
complication related to the vascular system is
thrombosis, both arterial and venous. Aortic
thrombus can be deadly given its ability to embolize
to vital organs, causing infarcts. The best management strategy and dose of anticoagulation to prevent or treat these thrombi are yet to be determined,
and we request our readers to conduct further
studies on it.
As COVID 19 is a reasonably new virus with a lot
yet to be determined about the disease syndrome it
causes, we request our readers to continue publishing data about its atypical features and
complications.
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